Supplemental_Tables - Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals: Biological Insights and Treatment Implications

Abstract

<p>Supplemental_Tables for Comparison of LDL-C Reduction Using Different Evolocumab Doses and Intervals: Biological Insights and Treatment Implications by Scott M. Wasserman, Marc S. Sabatine, Michael J. Koren, Robert P. Giugliano, Jason C. Legg, Maurice G. Emery, Sameer Doshi, Thomas Liu, Ransi Somaratne, and John P. Gibbs in Journal of Cardiovascular Pharmacology and Therapeutics</p